Terms: = Sarcomas AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Prognosis
17 results:
1. hsp90-regulated CHIP/TRIM21/p21 Axis Involves in the Senescence of Osteosarcoma Cells.
Xu GS; Lin YN; Zeng Q; Li ZP; Xiao T; Ye YS; Li ZY; Gao X
Protein Pept Lett; 2023; 30(6):513-519. PubMed ID: 37211848
[TBL] [Abstract] [Full Text] [Related]
2. Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced prognosis in Cancers.
Sheta M; Yoshida K; Kanemoto H; Calderwood SK; Eguchi T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982267
[TBL] [Abstract] [Full Text] [Related]
3. Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
Naito Y; Nishida T; Doi T
Gastric Cancer; 2023 May; 26(3):339-351. PubMed ID: 36913072
[TBL] [Abstract] [Full Text] [Related]
4. Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma.
Chen R; Guan Z; Zhong X; Zhang W; Zhang Y
Comput Math Methods Med; 2022; 2022():3197402. PubMed ID: 35069780
[TBL] [Abstract] [Full Text] [Related]
5. hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma.
Yao ZP; Zhu H; Shen F; Gong D
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):380-390. PubMed ID: 34767669
[TBL] [Abstract] [Full Text] [Related]
6. AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma.
Zheng D; Liu W; Xie W; Huang G; Jiang Q; Yang Y; Huang J; Xing Z; Yuan M; Wei M; Li Y; Yin J; Shen J; Shi Z
Signal Transduct Target Ther; 2021 Jan; 6(1):25. PubMed ID: 33468990
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptional regulation of Runx2 by hsp90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of heat shock protein 90 exerts an antitumour effect in angiosarcoma: involvement of the vascular endothelial growth factor signalling pathway.
Yamada-Kanazawa S; Kajihara I; Fukushima S; Jinnin M; Masuzawa M; Masuzawa M; Amoh Y; Hoshina D; Abe R; Ihn H
Br J Dermatol; 2017 Aug; 177(2):456-469. PubMed ID: 28078663
[TBL] [Abstract] [Full Text] [Related]
9. Elevated expression of hsp90 and the antitumor effect of an hsp90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma.
Bekki H; Kohashi K; Maekawa A; Yamada Y; Yamamoto H; Harimaya K; Hakozaki M; Nabeshima K; Iwamoto Y; Oda Y
BMC Cancer; 2015 Oct; 15():804. PubMed ID: 26502919
[TBL] [Abstract] [Full Text] [Related]
10. hsp90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas.
Ernst A; Anders H; Kapfhammer H; Orth M; Hennel R; Seidl K; Winssinger N; Belka C; Unkel S; Lauber K
Cancer Lett; 2015 Sep; 365(2):211-22. PubMed ID: 26044951
[TBL] [Abstract] [Full Text] [Related]
11. A purine scaffold hsp90 inhibitor BIIB021 has selective activity against KSHV-associated primary effusion lymphoma and blocks vFLIP K13-induced NF-κB.
Gopalakrishnan R; Matta H; Chaudhary PM
Clin Cancer Res; 2013 Sep; 19(18):5016-26. PubMed ID: 23881928
[TBL] [Abstract] [Full Text] [Related]
12. Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.
Nakajima K; Yanagawa T; Watanabe H; Takagishi K
Oncol Rep; 2012 Dec; 28(6):1953-8. PubMed ID: 23027359
[TBL] [Abstract] [Full Text] [Related]
13. Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy?
Yao C; Wei JJ; Wang ZY; Ding HM; Li D; Yan SC; Yang YJ; Gu ZP
Cell Biochem Biophys; 2013 Mar; 65(2):217-27. PubMed ID: 23015227
[TBL] [Abstract] [Full Text] [Related]
14. Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma.
Chen MH; Lin KJ; Yang WL; Kao YW; Chen TW; Chao SC; Chang PM; Liu CY; Tzeng CH; Chao Y; Chen MH; Yeh CN; Huang CY
Cancer; 2013 Jan; 119(2):293-303. PubMed ID: 22810956
[TBL] [Abstract] [Full Text] [Related]
15. Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate hsp90, and induce apoptosis in gastrointestinal stromal tumors.
Mühlenberg T; Zhang Y; Wagner AJ; Grabellus F; Bradner J; Taeger G; Lang H; Taguchi T; Schuler M; Fletcher JA; Bauer S
Cancer Res; 2009 Sep; 69(17):6941-50. PubMed ID: 19706776
[TBL] [Abstract] [Full Text] [Related]
16. [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].
Ozger H; Eralp L; Atalar AC; Toker B; Esberk Ateş L; Sungur M; Bilgiç B; Ayan I
Acta Orthop Traumatol Turc; 2009; 43(1):28-34. PubMed ID: 19293613
[TBL] [Abstract] [Full Text] [Related]
17. hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models.
Terry J; Lubieniecka JM; Kwan W; Liu S; Nielsen TO
Clin Cancer Res; 2005 Aug; 11(15):5631-8. PubMed ID: 16061882
[TBL] [Abstract] [Full Text] [Related]
